Literature DB >> 15028146

The cell cycle: accelerators, brakes, and checkpoints.

Stacey M Ivanchuk1, James T Rutka.   

Abstract

PROLIFERATIVE CUES TRIGGER a complex series of molecular signaling events in cells. Early in the cell cycle, cells are faced with an important decision that affects their fate. They either initiate a round of replication or they withdraw from cell division. Passage through the restriction point, or "point of no return," marks cellular commitment to a new round of division. Genetic mutations that predispose individuals to tumorigenesis often affect pathways that influence cellular proliferation. Many of the mutated genes give rise to molecules that are no longer able to appropriately regulate the mammalian cell cycle; the end result is neoplasia. In this review, the critical elements that permit cell cycle progression and the positive and negative regulators that affect the process are reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028146     DOI: 10.1227/01.neu.0000109534.28063.5d

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  10 in total

1.  A46, a benzothiophene-derived compound, suppresses Jak2-mediated pathologic cell growth.

Authors:  Anurima Majumder; Andrew T Magis; Sung O Park; Nicholas C Figueroa; Rebekah Baskin; Annet Kirabo; Robert W Allan; Zhizhuang Joe Zhao; Kirpal S Bisht; György M Keseru; Peter P Sayeski
Journal:  Exp Hematol       Date:  2011-10-20       Impact factor: 3.084

2.  Glypican-1 stimulates Skp2 autoinduction loop and G1/S transition in endothelial cells.

Authors:  Dianhua Qiao; Kristy Meyer; Andreas Friedl
Journal:  J Biol Chem       Date:  2011-12-27       Impact factor: 5.157

3.  Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer.

Authors:  Christelle P El-Haibi; Rajesh Singh; Pranav Gupta; Praveen K Sharma; Krysta N Greenleaf; Shailesh Singh; James W Lillard
Journal:  J Proteomics Bioinform       Date:  2012

4.  Immunohistochemical expression of cell-cycle regulators in pediatric embryonal brain tumors.

Authors:  Maria Moschovi; George A Alexiou; Amalia Patereli; George Siozos; George Sfakianos; Neofytos Prodromou; Kalliopi Stefanaki
Journal:  J Neurooncol       Date:  2012-07-05       Impact factor: 4.130

Review 5.  Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy.

Authors:  Yingmei Wang; Ping Ji; Jinsong Liu; Russell R Broaddus; Fengxia Xue; Wei Zhang
Journal:  Mol Cancer       Date:  2009-02-13       Impact factor: 27.401

6.  The cell cycle time of CD8+ T cells responding in vivo is controlled by the type of antigenic stimulus.

Authors:  Heesik Yoon; Taeg S Kim; Thomas J Braciale
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

7.  Sulfasalazine intensifies temozolomide cytotoxicity in human glioblastoma cells.

Authors:  Raffaela Silvestre Ignarro; Gustavo Facchini; André Schwambach Vieira; Daniela Rodrigues De Melo; Iscia Lopes-Cendes; Roger Frigério Castilho; Fabio Rogerio
Journal:  Mol Cell Biochem       Date:  2016-06-23       Impact factor: 3.396

8.  Novel EGFR-TK inhibitor EKB-569 inhibits hepatocellular carcinoma cell proliferation by AKT and MAPK pathways.

Authors:  Heesue Kim; Ho Yeong Lim
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

9.  A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).

Authors:  David Van Mater; Sridharan Gururangan; Oren Becher; Olivia Campagne; Sarah Leary; Joanna J Phillips; Jie Huang; Tong Lin; Tina Young Poussaint; Stewart Goldman; Patricia Baxter; Girish Dhall; Giles Robinson; Mariko DeWire-Schottmiller; Eugene I Hwang; Clinton F Stewart; Arzu Onar-Thomas; Ira J Dunkel; Maryam Fouladi
Journal:  Pediatr Blood Cancer       Date:  2021-01-06       Impact factor: 3.838

10.  MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis.

Authors:  Yangyang Wang; Jiping Zeng; Jianyong Pan; Xue Geng; Lupeng Li; Jing Wu; Ping Song; Ying Wang; Jilan Liu; Lixiang Wang
Journal:  Oncotarget       Date:  2016-05-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.